PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Carcinoma 433,099 Disease Target Adenosine Deaminase 6,613 90 0.00 -0.99 0.01 0.53
Carcinoma 433,099 Disease Target CCL27/CTACK 5 1 0.00 -0.89 0.20 0.56
Carcinoma 433,099 Disease Target Dihydrofolate Reductase 5,563 135 0.00 -0.99 0.02 0.55
Carcinoma 433,099 Disease Target Annexin A1 406 40 0.00 -0.95 0.10 0.57
Carcinoma 433,099 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.57
Carcinoma 433,099 Disease Target CCL14 34 1 0.00 -0.99 0.03 0.53
Carcinoma 433,099 Disease Target APOA2 118 6 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target BMX 185 9 0.00 -0.98 0.05 0.55
Carcinoma 433,099 Disease Target Ricin 3,034 88 0.00 -0.99 0.03 0.55
Carcinoma 433,099 Disease Target Glutathione S-Transferase A1 111 5 0.00 -0.98 0.05 0.55
Carcinoma 433,099 Disease Target CCL2 3,560 84 0.00 -0.99 0.02 0.55
Carcinoma 433,099 Disease Target Glutathione S-Transferase A3 15 2 0.00 -0.93 0.13 0.56
Carcinoma 433,099 Disease Target Glutathione S-Transferase A2 25 1 0.00 -0.98 0.04 0.54
Carcinoma 433,099 Disease Target Urokinase-Type Plasminogen Activator 3,939 463 0.01 -0.94 0.12 0.60
Carcinoma 433,099 Disease Target Antithrombin 13,773 140 0.00 -0.99 0.01 0.53
Carcinoma 433,099 Disease Target Cytochrome B 6,185 13 0.00 -1.00 0.00 0.48
Carcinoma 433,099 Disease Target ERK2 3,287 125 0.00 -0.98 0.04 0.56
Carcinoma 433,099 Disease Target CHK2 1,391 125 0.01 -0.95 0.09 0.58
Carcinoma 433,099 Disease Target DMPK 609 2 0.00 -1.00 0.00 0.49
Carcinoma 433,099 Disease Target CHK1 2,044 114 0.00 -0.97 0.06 0.57
Carcinoma 433,099 Disease Target APOE 12,771 28 0.00 -1.00 0.00 0.48
Carcinoma 433,099 Disease Target EPHA3 140 14 0.00 -0.95 0.10 0.57
Carcinoma 433,099 Disease Target BMP-7 1,112 20 0.00 -0.99 0.02 0.53
Carcinoma 433,099 Disease Target CER 2,421 61 0.00 -0.99 0.03 0.55
Carcinoma 433,099 Disease Target Gonadotropin-Releasing Hormone Receptor 493 12 0.00 -0.99 0.02 0.54
Carcinoma 433,099 Disease Target FABP1 90 4 0.00 -0.98 0.04 0.55
Carcinoma 433,099 Disease Target Alpha-Amylase 7,171 40 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target Dna Polymerase I 1,993 3 0.00 -1.00 0.00 0.48
Carcinoma 433,099 Disease Target Endothelin A Receptor 722 31 0.00 -0.98 0.04 0.55
Carcinoma 433,099 Disease Target BRSK1 20 1 0.00 -0.97 0.05 0.54
Carcinoma 433,099 Disease Target CD154 1,512 23 0.00 -0.99 0.02 0.53
Carcinoma 433,099 Disease Target CD146 729 24 0.00 -0.98 0.03 0.55
Carcinoma 433,099 Disease Target Microtubule-Associated Protein 1a 73 3 0.00 -0.98 0.04 0.54
Carcinoma 433,099 Disease Target EPHB2 385 18 0.00 -0.98 0.05 0.55
Carcinoma 433,099 Disease Target Kallikrein-6 79 10 0.00 -0.93 0.13 0.57
Carcinoma 433,099 Disease Target Kallikrein-8 19 2 0.00 -0.95 0.11 0.56
Carcinoma 433,099 Disease Target CXCL10/IP-10 114 1 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target EG-VEGF 63 6 0.00 -0.95 0.10 0.56
Carcinoma 433,099 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 14 0.00 -0.98 0.04 0.55
Carcinoma 433,099 Disease Target Glutaredoxin-1 142 1 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target CAPG 85 7 0.00 -0.96 0.08 0.56
Carcinoma 433,099 Disease Target Collagen 138,882 2,684 0.01 -0.99 0.02 0.56
Carcinoma 433,099 Disease Target Collagenase 3 367 27 0.00 -0.96 0.07 0.56
Carcinoma 433,099 Disease Target CXCL9 1,016 39 0.00 -0.98 0.04 0.55
Carcinoma 433,099 Disease Target Arachidonate 5-Lipoxygenase 170 1 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target CD95 4,266 259 0.01 -0.97 0.06 0.58
Carcinoma 433,099 Disease Target Cox-2 21,583 1,749 0.02 -0.96 0.08 0.60
Carcinoma 433,099 Disease Target Carbonic Anhydrase 9 150 54 0.01 -0.80 0.36 0.60
Carcinoma 433,099 Disease Target Carbonic Anhydrase 3 36 1 0.00 -0.99 0.03 0.53
Carcinoma 433,099 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.56
Carcinoma 433,099 Disease Target Apo I 55 1 0.00 -0.99 0.02 0.53
Carcinoma 433,099 Disease Target AHSG 176 7 0.00 -0.98 0.04 0.55
Carcinoma 433,099 Disease Target Insulin-Degrading Enzyme 558 1 0.00 -1.00 0.00 0.48
Carcinoma 433,099 Disease Target CCL3 1,427 21 0.00 -0.99 0.01 0.53
Carcinoma 433,099 Disease Target Lysosomal Alpha-Glucosidase 105 2 0.00 -0.99 0.02 0.53
Carcinoma 433,099 Disease Target Angiotensin-Converting Enzyme 2 665 4 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target C7 7,027 66 0.00 -1.00 0.01 0.52
Carcinoma 433,099 Disease Target Vanilloid Receptor 1 404 5 0.00 -0.99 0.01 0.52
Carcinoma 433,099 Disease Target Sphingomyelinase 3,060 47 0.00 -0.99 0.02 0.53
Carcinoma 433,099 Disease Target Proteinase-Activated Receptor 1 133 8 0.00 -0.97 0.06 0.55
Carcinoma 433,099 Disease Target Epiregulin 291 28 0.00 -0.95 0.10 0.57
Carcinoma 433,099 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.57
Carcinoma 433,099 Disease Target Alpha-1 AntiChymotrypsin 1,460 131 0.01 -0.95 0.09 0.58
Carcinoma 433,099 Disease Target Aurora Kinase A 196 19 0.00 -0.95 0.10 0.57
Carcinoma 433,099 Disease Target ANGPT2 105 7 0.00 -0.97 0.07 0.56
Carcinoma 433,099 Disease Target ERBB4 994 79 0.00 -0.96 0.08 0.57
Carcinoma 433,099 Disease Target AURKC 26 1 0.00 -0.98 0.04 0.54
Carcinoma 433,099 Disease Target Ent2 108 1 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target ARAP 68 1 0.00 -0.99 0.01 0.52
Carcinoma 433,099 Disease Target Aurora A kinase 318 19 0.00 -0.97 0.06 0.56
Carcinoma 433,099 Disease Target CEBP alpha 26 2 0.00 -0.96 0.08 0.55
Carcinoma 433,099 Disease Target BMP-4 1,255 35 0.00 -0.99 0.03 0.54
Carcinoma 433,099 Disease Target Toll-Like Receptor 2 2,174 26 0.00 -0.99 0.01 0.52
Carcinoma 433,099 Disease Target Platelet Activating Factor 9,915 44 0.00 -1.00 0.00 0.50
Carcinoma 433,099 Disease Target Cytokeratin 8 587 143 0.01 -0.87 0.24 0.60
Carcinoma 433,099 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.54
Carcinoma 433,099 Disease Target EPHB1 137 16 0.00 -0.94 0.12 0.57
Carcinoma 433,099 Disease Target EGF 27,487 2,692 0.02 -0.95 0.10 0.62
Carcinoma 433,099 Disease Target BRK 236 26 0.00 -0.94 0.11 0.57
Carcinoma 433,099 Disease Target Renin 43,456 208 0.00 -1.00 0.00 0.50
Carcinoma 433,099 Disease Target Bile Salt Export Pump 476 11 0.00 -0.99 0.02 0.54
Carcinoma 433,099 Disease Target CD137 474 23 0.00 -0.98 0.05 0.55
Carcinoma 433,099 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.55
Carcinoma 433,099 Disease Target D-Dimer 6,185 73 0.00 -0.99 0.01 0.53
Carcinoma 433,099 Disease Target CLK1 62 1 0.00 -0.99 0.02 0.52
Carcinoma 433,099 Disease Target BTK 1,263 13 0.00 -0.99 0.01 0.52
Carcinoma 433,099 Disease Target Carbonic Anhydrase III 272 1 0.00 -1.00 0.00 0.50
Carcinoma 433,099 Disease Target Multidrug Resistance-Associated Protein 2 462 15 0.00 -0.98 0.03 0.54
Carcinoma 433,099 Disease Target Retinoic Acid Receptor Alpha 1,068 51 0.00 -0.98 0.05 0.56
Carcinoma 433,099 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.57
Carcinoma 433,099 Disease Target APOC1 126 3 0.00 -0.99 0.02 0.53
Carcinoma 433,099 Disease Target AGP 2,006 28 0.00 -0.99 0.01 0.53
Carcinoma 433,099 Disease Target BMPR1A 279 14 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target ADRP 537 3 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target CXCL11 526 18 0.00 -0.98 0.03 0.55
Carcinoma 433,099 Disease Target CXCL3 145 8 0.00 -0.97 0.06 0.55
Carcinoma 433,099 Disease Target DNA-damage-inducible transcript 3 30 3 0.00 -0.95 0.10 0.56
Carcinoma 433,099 Disease Target Metabotropic Glutamate Receptor 1 221 3 0.00 -0.99 0.01 0.52
Carcinoma 433,099 Disease Target AMY1A 13 1 0.00 -0.96 0.08 0.55
Carcinoma 433,099 Disease Target Udp-Glucuronosyltransferase 2,219 47 0.00 -0.99 0.02 0.54